| Name | Title | Contact Details |
|---|---|---|
Charles Bodner |
Executive Vice President and Chief Operating Officer | Profile |
Gavin Nichols |
Chief Information Officer and Executive Vice President of Technology | Profile |
Gavin Nichols |
Chief Information Officer and Executive Vice President of Technology | Profile |
Andrew Masters |
Chief Technology Officer | Profile |
Michael Anderson |
Senior Director of Corporate Information Technology | Profile |
Wellington Parc Of Owensboro is a Owensboro, KY-based company in the Healthcare, Pharmaceuticals, and Biotech sector.
Boston Microfluidics (BMF) is dedicated to connecting people to their health by increasing access to diagnostic testing for all people. Our technology is a unique combination of elegant sample processing solutions with an intuitive user interface. We strive to streamline current testing systems with devices that perform complex sample processing steps without the need for trained professionals or specialized laboratory equipment. We also seek to simplify diagnostic tests so that they can be used efficiently at the point of care, or even be available for direct sale to consumers. Above all, BMF works to help provide patients with the information they need to make choices about their health.
Avalon Healthcare is a Tampa, FL-based company in the Healthcare, Pharmaceuticals, and Biotech sector.
Alector is combining state-of-the-art antibody technology and recent discoveries in neuroimmunology and human genetics to develop novel therapeutics for Alzheimer`s disease, other forms of dementia, and mechanistically related neurodegenerative disorders. Alector`s strategy is to efficiently generate and validate antibody drugs with unique functional properties that engage key disease-altering targets. This approach is enabled by a strategic alliance with Adimab, the industry leader in discovery and optimization of antibody therapeutics. Alector is currently developing leads for 4 major targets and anticipates taking 2 of these through pre-clinical development and IND enabling studies within 24 months. Alector has incorporated a highly integrated and lean biotechnology structure with extensive outsourcing that supports core scientific and management teams.
The HealthMyne Quantitative Imaging Decision Support (QIDS)® software platform and its Rapid Precise Metrics (RPM)™ functionality transform multiple clinical decision support workflows by combining quantitative imaging metrics with relevant patient information.